In the Zone

$NVAX– Novavax, Inc.

 

Novavax, Inc. is a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company is headquartered in Gaither Burg , Maryland and has over a decade of experience dealing with some of the worlds most devastating diseases, including Ebola, SARS, MERS , as wellas COVID-19.

 

The stock has been on a decline for three of the past four months after declining in late August coming from a recent price low of $80.71. What Im looking for in the days ahead is a price break above $143.10 in order to take this stock higher to the upside. 

 

As the market came to a close on Friday the stock ended the day trading at $125.69 up 23.09 or 22.50% on heavier than average trading volume of 11.77 million. That’s a 160% increase in volume in one day with its average daily trading volume at 4.52 million.

 

In the week ahead keep $NVAX Novavax on your watch list for a continued advance to the upside. 

 

  

By Marlin Rolle

 

Please note that all the stocks listed are not buy recommendations; please do your own due diligence or get help from a professional before trading.